27 to the Eye Care Center at AU Medical Center. I dont want to sound alarmist, the 74 year-old from Clearwater, S.C., begins, but I think my eyes might last longer than I do. Well, thats my job, Nussbaum said, chuckling. After battling diabetes for nearly 40 years, Lowe has developed diabetic retinopathy, a consequence of uncontrolled diabetes that can damage small blood vessels in the eye and is the leading cause of blindness among working-age adults. A researcher across campus from the clinic is looking at a different way of potentially blocking the inflammation that can lead to that damage through a potential new drug. Dr. Shruti Sharma of the Center for Biotechnology and Genomic Medicine has a $1.5 million grant from the National Eye Institute to look at basic research into blocking inflammation among epithelial cells in light-sensing retina in the eye, Sharma is looking at a well-known agent in inflammation called interleukin-6 that can affect those cells even though they lack the receptor normally needed for such interaction, an effect called trans-signaling. While that effect had been known for a while it is not something that researchers had focused on in the past, she said. http://advisingeyesurgeon.beatthetrain.org/2016/12/05/getting-advice-on-swift-products-in-eye-surgery/Sharma is looking at an experimental drug that in her early work seems to have blocked that type of action in those cells, using it both in the lab in human cells in the same kind of environment that is there in the eye and in a mouse model of diabetes. The hope is to prevent the barrier disruption to the cells that can cause them to become leaky and create inflammation, an early hallmark of the disease. The mouse model allows Sharma to test the compound in both late and early stages of the disease to see if it she can prevent diabetic retinopathy from happening, she said. Separately, the compound is being tested in human clinical trials in rheumatoid arthritis, which is also promising, Sharma said.
For the original version including any supplementary images or video, visit http://www.washingtontimes.com/news/2017/jan/1/new-drug-might-help-with-diabetes-related-blindnes/?utm_source=RSS_Feed&utm_medium=RSS
However, the cataracts usually aren’t totally symmetrical, and the cataract in one eye may be more advanced than the other. http://dclakers.com/advisingeyesurgeon/2016/12/05/a-closer-look-at-strategies-of-cataracts/Your eye care professional uses a special magnifying lens to examine your retina and optic nerve for signs of damage and other eye problems. You will need to insert, remove, and clean the lenses on a regular basis. Other things that can raise your risk of getting cataracts include cigarette smoke, air pollution, and heavy drinking. As cataracts develop very slowly most people do not know they have them at first. When you are home, try not to bend from the waist to pick up objects on the floor. A cataract is a clouding of the normally clear lens of the eye. Often, only part-time use of reading glasses is needed after cataract surgery with mono focal cols. A cataract may not need to be removed right away if your lifestyle isn’t significantly affected. You may notice that your vision is blurred a little, like looking through a cloudy piece of glass or viewing an impressionist painting.